As of Jul 02
| -0.25 / -1.35%|
The 5 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 19.00, with a high estimate of 22.00 and a low estimate of 15.00. The median estimate represents a +3.77% increase from the last price of 18.31.
The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.